Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Finasteride may cause long-lasting sexual side effects.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Finasteride helps reduce priapism in sickle cell anemia patients.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Over-the-counter products can help with menopause symptoms, but be aware of their ingredients.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Testosterone's role in women's sex drive is unclear and needs more research, as low levels don't always mean less sexual interest and high levels can cause side effects.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Man stopped medications due to sexual side effects, found relief with prostatic artery embolisation.

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

Finasteride may help reduce inappropriate sexual behaviors in dementia patients with prostate issues.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Barn owls with smaller black spots have higher testosterone levels, which might be due to genetic effects on hormone regulation rather than hormone effects on coloration.

Women with PCOS are more likely to experience sexual dysfunction, but lifestyle changes and weight loss can improve sexual function.

Hair loss in women linked to higher sexual dysfunction risk.

5α-reductase-2 deficiency causes ambiguous genitalia at birth and affects male sexual development, but individuals often develop male characteristics at puberty.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.